Biodistribution and Radiation Dosimetry of the Carbonic Anhydrase IX Imaging Agent [18 F]VM4-037 Determined from PET/CT Scans in Healthy Volunteers

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics

(2015) Paul C. McDonald et al.   Oncotarget

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification

(2012) A S Betof et al.   BRITISH JOURNAL OF CANCER

Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial

(2012) Chaitanya R. Divgi et al.   JOURNAL OF CLINICAL ONCOLOGY

Biodistribution and Radiation Dosimetry of the Integrin Marker 18F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans

(2012) M. Doss et al.   JOURNAL OF NUCLEAR MEDICINE

The disturbed blood–brain barrier in human glioblastoma

(2012) Hartwig Wolburg et al.   MOLECULAR ASPECTS OF MEDICINE

18F-HX4 hypoxia imaging with PET/CT in head and neck cancer

(2012) Limin Chen et al.   NUCLEAR MEDICINE COMMUNICATIONS

Interfering with pH regulation in tumours as a therapeutic strategy

(2011) Dario Neri et al.   NATURE REVIEWS DRUG DISCOVERY

High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

(2010) M İlie et al.   BRITISH JOURNAL OF CANCER

Hypoxic regulation of cytoglobin and neuroglobin expression in human normal and tumor tissues

(2010) Marwan Emara et al.   Cancer Cell International

Expression and Activity of Carbonic Anhydrase IX Is Associated With Metabolic Dysfunction in MDA-MB-231 Breast Cancer Cells

(2009) Ying Li et al.   CANCER INVESTIGATION

Carbonic anhydrase IX in oligodendroglial brain tumors

(2008) Sally Järvelä et al.   BMC CANCER

Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma

(2008) N Tanaka et al.   BRITISH JOURNAL OF CANCER

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

(2008) Jean-Jacques Patard et al.   INTERNATIONAL JOURNAL OF CANCER

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

(2008) Claudiu T. Supuran   NATURE REVIEWS DRUG DISCOVERY

Carbonic anhydrase IX: A new druggable target for the design of antitumor agents

(2007) Jean-Yves Winum et al.   MEDICINAL RESEARCH REVIEWS